PTAC

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NamePTAC

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMuscarinic acetylcholine receptor M1 antagonistsMuscarinic acetylcholine receptor M4 agonistsMuscarinic acetylcholine receptor M2 agonists +[5]

TargetsMuscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M4Muscarinic acetylcholine receptor M3 +[5]

Therapy Area/IndicationsPsychotic Disorders

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesEli Lilly And Company Novo Nordisk A/S

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesEli Lilly And Company

Active IndicationsN/A

Inactive IndicationsPsychotic Disorders

Other Information

ATC CodeN/A